Literature DB >> 7929356

The binding site on human immunoglobulin E for its high affinity receptor.

L Presta1, R Shields, L O'Connell, S Lahr, J Porter, C Gorman, P Jardieu.   

Abstract

Immunoglobulin (Ig) E antibodies mediate allergic responses by binding to specific high affinity receptors, Fc epsilon RI, on mast cells and basophils. Previous studies have shown that the principal Fc epsilon RI binding site is located on the third constant domain, Fc epsilon 3, of IgE. Based on a model of the IgE Fc epsilon 3 (which is homologous to the second constant domain of IgG), homology scanning mutagenesis and replacement of individual residues were used to determine the specific amino acids of human IgE involved in binding to human Fc epsilon RI. The amino acids are localized in three loops, which form a putative ridge on the most exposed side of the Fc epsilon 3 domain of IgE and include Arg-408, Ser-411, Lys-415, Glu-452, Arg-465, and Met-469. The preponderance of charged residues suggests that IgE-Fc epsilon RI binding is mediated primarily by electrostatic interaction. Furthermore, it is possible to confer Fc epsilon RI binding to an IgG molecule by introducing these three IgE loops into the IgG C gamma 2 domain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929356

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  The Role of Type 2 Inflammation in the Pathogenesis of Asthma Exacerbations.

Authors:  Eleanor M Dunican; John V Fahy
Journal:  Ann Am Thorac Soc       Date:  2015-11

Review 2.  Omalizumab: a monoclonal anti-IgE antibody.

Authors:  Paul P Belliveau
Journal:  MedGenMed       Date:  2005-01-27

3.  Structure of the omalizumab Fab.

Authors:  Rasmus K Jensen; Melanie Plum; Luna Tjerrild; Thilo Jakob; Edzard Spillner; Gregers Rom Andersen
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-03-20       Impact factor: 1.056

4.  Antigen 43/Fcε3 chimeric protein expressed by a novel bacterial surface expression system as an effective asthma vaccine.

Authors:  Feng-Ying Huang; Cai-Chun Wang; Yong-Hao Huang; Huan-Ge Zhao; Jun-Li Guo; Song-Lin Zhou; Hua Wang; Ying-Ying Lin; Guang-Hong Tan
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

Review 5.  Monoclonal antibodies for the treatment of severe asthma.

Authors:  Salvatore Clienti; Jaymin B Morjaria; Elisa Basile; Riccardo Polosa
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

6.  Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma.

Authors:  Philip J Lowe; Stacey Tannenbaum; Aurelie Gautier; Pablo Jimenez
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

Review 7.  Assessment and significance of protein-protein interactions during development of protein biopharmaceuticals.

Authors:  Sandeep Yadav; Jun Liu; Thomas M Scherer; Yatin Gokarn; Barthélemy Demeule; Sonoko Kanai; James D Andya; Steven J Shire
Journal:  Biophys Rev       Date:  2013-03-14

8.  Unusual asthma syndromes and their management.

Authors:  Jaymin B Morjaria; Jack A Kastelik
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

Review 9.  Is there a role for treatment of asthma with omalizumab?

Authors:  H Milgrom
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

10.  Mutations in an avian IgY-Fc fragment reveal the locations of monocyte Fc receptor binding sites.

Authors:  Alexander I Taylor; Brian J Sutton; Rosaleen A Calvert
Journal:  Dev Comp Immunol       Date:  2009-09-11       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.